Design, synthesis and in vitro evaluation of some small molecules malonyl CoA decarboxylase inhibitors containing pyrazoline scaffold and study of their binding interactions with malonyl CoA decarboxylase via preliminary docking simulation

2017 ◽  
Vol 26 (9) ◽  
pp. 2127-2140 ◽  
Author(s):  
Deepali M. Jagdale ◽  
C. S. Ramaa
2021 ◽  
Vol 36 (1) ◽  
pp. 1370-1377
Author(s):  
Daniel A. S. Kitagawa ◽  
Rafael B. Rodrigues ◽  
Thiago N. Silva ◽  
Wellington V. dos Santos ◽  
Vinicius C. V. da Rocha ◽  
...  

ChemMedChem ◽  
2021 ◽  
Author(s):  
Walter Damián Guerra ◽  
Daniel Lucena-Agell ◽  
Rafael Hortigüela ◽  
Roberto Arturo Rossi ◽  
J. Fernando Díaz ◽  
...  

Author(s):  
Birgit Masjost ◽  
Patrick Ballmer ◽  
Edilio Borroni ◽  
Gerhard Zürcher ◽  
Fritz K. Winkler ◽  
...  

2004 ◽  
Vol 12 (20) ◽  
pp. 5453-5463 ◽  
Author(s):  
Stefano Manfredini ◽  
Silvia Vertuani ◽  
Barbara Pavan ◽  
Federica Vitali ◽  
Martina Scaglianti ◽  
...  

2016 ◽  
Vol 26 (12) ◽  
pp. 2931-2935 ◽  
Author(s):  
Zhimin Zhang ◽  
Shaohua Hou ◽  
Hongli Chen ◽  
Ting Ran ◽  
Fei Jiang ◽  
...  

2007 ◽  
Vol 18 (7) ◽  
pp. 814-816 ◽  
Author(s):  
Jing Yang ◽  
Xiaofang Wang ◽  
Hui Wen ◽  
Fang Qin ◽  
Guang Zhong Yang

Molecules ◽  
2019 ◽  
Vol 25 (1) ◽  
pp. 10 ◽  
Author(s):  
Hehua Xiong ◽  
Jianxin Cheng ◽  
Jianqing Zhang ◽  
Qian Zhang ◽  
Zhen Xiao ◽  
...  

A series of 4-(pyridin-4-yloxy)benzamide derivatives containing a 1,2,3-triazole fragment were designed, synthesized, and their inhibitory activity against A549, HeLa, and MCF-7 cancer cell lines was evaluated. Most compounds exhibited moderate to potent antitumor activity against the three cell lines. Among them, the promising compound B26 showed stronger inhibitory activity than Golvatinib, with IC50 values of 3.22, 4.33, and 5.82 μM against A549, HeLa, and MCF-7 cell lines, respectively. The structure–activity relationships (SARs) demonstrated that the modification of the terminal benzene ring with a single electron-withdrawing substituent (fluorine atom) and the introduction of a pyridine amide chain with a strong hydrophilic group (morpholine) to the hinge region greatly improved the antitumor activity. Meanwhile, the optimal compound B26 showed potent biological activity in some pharmacological experiments in vitro, such as cell morphology study, dose-dependent test, kinase activity assay, and cell cycle experiment. Finally, the molecular docking simulation was performed to further explore the binding mode of compound B26 with c-Met.


2019 ◽  
Vol 92 ◽  
pp. 103281 ◽  
Author(s):  
Ramu Manjula ◽  
Nikhila Gokhale ◽  
Sruthi Unni ◽  
Prashant Deshmukh ◽  
Rajkumar Reddyrajula ◽  
...  

2013 ◽  
Vol 21 (17) ◽  
pp. 5107-5117 ◽  
Author(s):  
Marjorie Bruder ◽  
Débora Barbosa Vendramini-Costa ◽  
João Ernesto de Carvalho ◽  
Ronaldo Aloise Pilli

Sign in / Sign up

Export Citation Format

Share Document